HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

Saved in:
Bibliographic Details
Published in:Oncotarget 2015-10, Vol.6 (31), p.31134-31150
Main Authors: Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3
cites cdi_FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3
container_end_page 31150
container_issue 31
container_start_page 31134
container_title Oncotarget
container_volume 6
creator Canella, Alessandro
Nieves, Hector Cordero
Sborov, Douglas W.
Cascione, Luciano
Radomska, Hanna S.
Smith, Emily
Stiff, Andrew
Consiglio, Jessica
Caserta, Enrico
Rizzotto, Lara
Zanesi, Nicola
Stefano, Volinia
Kaur, Balveen
Mo, Xiaokui
Byrd, John C.
Efebera, Yvonne A.
Hofmeister, Craig C.
Pichiorri, Flavia
description
doi_str_mv 10.18632/oncotarget.5290
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_18632_oncotarget_5290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_18632_oncotarget_5290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3</originalsourceid><addsrcrecordid>eNpNkM1KxDAYRYMoOIyzd5kX6JikaZMsh446woAgunJR0uSrRtJkSLJwfHrrD-jd3AMX7uIgdEnJmsq2ZlcxmFh0eoGybpgiJ2hBFVcVa5r69B-fo1XOb2ROw4VkaoGed9tNh114dYMrMeHNQ8UZtmAS6AwZd1vOMbwfEuTsYsA6WJwhZFfcxzxPR_Bx0tiA9xmXiD0E7Z2Nk7Nwgc5G7TOsfnuJnm6uH7tdtb-_ves2-8owxkvVyLE2wtpBSkotJXKgMyk7CKvbwQBo0o5UCTYypTk1XNqGCMqlNEJSgHqJyM-vSTHnBGN_SG7S6dhT0n_76f_89F9-6k9Pi1us</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide</title><source>Open Access: PubMed Central</source><creator>Canella, Alessandro ; Nieves, Hector Cordero ; Sborov, Douglas W. ; Cascione, Luciano ; Radomska, Hanna S. ; Smith, Emily ; Stiff, Andrew ; Consiglio, Jessica ; Caserta, Enrico ; Rizzotto, Lara ; Zanesi, Nicola ; Stefano, Volinia ; Kaur, Balveen ; Mo, Xiaokui ; Byrd, John C. ; Efebera, Yvonne A. ; Hofmeister, Craig C. ; Pichiorri, Flavia</creator><creatorcontrib>Canella, Alessandro ; Nieves, Hector Cordero ; Sborov, Douglas W. ; Cascione, Luciano ; Radomska, Hanna S. ; Smith, Emily ; Stiff, Andrew ; Consiglio, Jessica ; Caserta, Enrico ; Rizzotto, Lara ; Zanesi, Nicola ; Stefano, Volinia ; Kaur, Balveen ; Mo, Xiaokui ; Byrd, John C. ; Efebera, Yvonne A. ; Hofmeister, Craig C. ; Pichiorri, Flavia</creatorcontrib><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.5290</identifier><language>eng</language><ispartof>Oncotarget, 2015-10, Vol.6 (31), p.31134-31150</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3</citedby><cites>FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Canella, Alessandro</creatorcontrib><creatorcontrib>Nieves, Hector Cordero</creatorcontrib><creatorcontrib>Sborov, Douglas W.</creatorcontrib><creatorcontrib>Cascione, Luciano</creatorcontrib><creatorcontrib>Radomska, Hanna S.</creatorcontrib><creatorcontrib>Smith, Emily</creatorcontrib><creatorcontrib>Stiff, Andrew</creatorcontrib><creatorcontrib>Consiglio, Jessica</creatorcontrib><creatorcontrib>Caserta, Enrico</creatorcontrib><creatorcontrib>Rizzotto, Lara</creatorcontrib><creatorcontrib>Zanesi, Nicola</creatorcontrib><creatorcontrib>Stefano, Volinia</creatorcontrib><creatorcontrib>Kaur, Balveen</creatorcontrib><creatorcontrib>Mo, Xiaokui</creatorcontrib><creatorcontrib>Byrd, John C.</creatorcontrib><creatorcontrib>Efebera, Yvonne A.</creatorcontrib><creatorcontrib>Hofmeister, Craig C.</creatorcontrib><creatorcontrib>Pichiorri, Flavia</creatorcontrib><title>HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide</title><title>Oncotarget</title><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpNkM1KxDAYRYMoOIyzd5kX6JikaZMsh446woAgunJR0uSrRtJkSLJwfHrrD-jd3AMX7uIgdEnJmsq2ZlcxmFh0eoGybpgiJ2hBFVcVa5r69B-fo1XOb2ROw4VkaoGed9tNh114dYMrMeHNQ8UZtmAS6AwZd1vOMbwfEuTsYsA6WJwhZFfcxzxPR_Bx0tiA9xmXiD0E7Z2Nk7Nwgc5G7TOsfnuJnm6uH7tdtb-_ves2-8owxkvVyLE2wtpBSkotJXKgMyk7CKvbwQBo0o5UCTYypTk1XNqGCMqlNEJSgHqJyM-vSTHnBGN_SG7S6dhT0n_76f_89F9-6k9Pi1us</recordid><startdate>20151013</startdate><enddate>20151013</enddate><creator>Canella, Alessandro</creator><creator>Nieves, Hector Cordero</creator><creator>Sborov, Douglas W.</creator><creator>Cascione, Luciano</creator><creator>Radomska, Hanna S.</creator><creator>Smith, Emily</creator><creator>Stiff, Andrew</creator><creator>Consiglio, Jessica</creator><creator>Caserta, Enrico</creator><creator>Rizzotto, Lara</creator><creator>Zanesi, Nicola</creator><creator>Stefano, Volinia</creator><creator>Kaur, Balveen</creator><creator>Mo, Xiaokui</creator><creator>Byrd, John C.</creator><creator>Efebera, Yvonne A.</creator><creator>Hofmeister, Craig C.</creator><creator>Pichiorri, Flavia</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20151013</creationdate><title>HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide</title><author>Canella, Alessandro ; Nieves, Hector Cordero ; Sborov, Douglas W. ; Cascione, Luciano ; Radomska, Hanna S. ; Smith, Emily ; Stiff, Andrew ; Consiglio, Jessica ; Caserta, Enrico ; Rizzotto, Lara ; Zanesi, Nicola ; Stefano, Volinia ; Kaur, Balveen ; Mo, Xiaokui ; Byrd, John C. ; Efebera, Yvonne A. ; Hofmeister, Craig C. ; Pichiorri, Flavia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Canella, Alessandro</creatorcontrib><creatorcontrib>Nieves, Hector Cordero</creatorcontrib><creatorcontrib>Sborov, Douglas W.</creatorcontrib><creatorcontrib>Cascione, Luciano</creatorcontrib><creatorcontrib>Radomska, Hanna S.</creatorcontrib><creatorcontrib>Smith, Emily</creatorcontrib><creatorcontrib>Stiff, Andrew</creatorcontrib><creatorcontrib>Consiglio, Jessica</creatorcontrib><creatorcontrib>Caserta, Enrico</creatorcontrib><creatorcontrib>Rizzotto, Lara</creatorcontrib><creatorcontrib>Zanesi, Nicola</creatorcontrib><creatorcontrib>Stefano, Volinia</creatorcontrib><creatorcontrib>Kaur, Balveen</creatorcontrib><creatorcontrib>Mo, Xiaokui</creatorcontrib><creatorcontrib>Byrd, John C.</creatorcontrib><creatorcontrib>Efebera, Yvonne A.</creatorcontrib><creatorcontrib>Hofmeister, Craig C.</creatorcontrib><creatorcontrib>Pichiorri, Flavia</creatorcontrib><collection>CrossRef</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canella, Alessandro</au><au>Nieves, Hector Cordero</au><au>Sborov, Douglas W.</au><au>Cascione, Luciano</au><au>Radomska, Hanna S.</au><au>Smith, Emily</au><au>Stiff, Andrew</au><au>Consiglio, Jessica</au><au>Caserta, Enrico</au><au>Rizzotto, Lara</au><au>Zanesi, Nicola</au><au>Stefano, Volinia</au><au>Kaur, Balveen</au><au>Mo, Xiaokui</au><au>Byrd, John C.</au><au>Efebera, Yvonne A.</au><au>Hofmeister, Craig C.</au><au>Pichiorri, Flavia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide</atitle><jtitle>Oncotarget</jtitle><date>2015-10-13</date><risdate>2015</risdate><volume>6</volume><issue>31</issue><spage>31134</spage><epage>31150</epage><pages>31134-31150</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><doi>10.18632/oncotarget.5290</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2015-10, Vol.6 (31), p.31134-31150
issn 1949-2553
1949-2553
language eng
recordid cdi_crossref_primary_10_18632_oncotarget_5290
source Open Access: PubMed Central
title HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A08%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HDAC%20inhibitor%20AR-42%20decreases%20CD44%20expression%20and%20sensitizes%20myeloma%20cells%20to%20lenalidomide&rft.jtitle=Oncotarget&rft.au=Canella,%20Alessandro&rft.date=2015-10-13&rft.volume=6&rft.issue=31&rft.spage=31134&rft.epage=31150&rft.pages=31134-31150&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.5290&rft_dat=%3Ccrossref%3E10_18632_oncotarget_5290%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c224t-58f3c7ddb8811d108b18819db7da6bceea06f1972f29a41c48d5071488c781ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true